Lansoprazolo Alter

Lansoprazole, the active ingredient in Lansoprazolo Alter, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑esophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome.

GNH USA supplies Lansoprazolo Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is indicated for several acid‑related gastrointestinal disorders.

- Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and esophageal irritation by lowering stomach acidity. - Peptic ulcer disease: promotes ulcer healing and prevents recurrence through acid suppression. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens by creating a less acidic environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion caused by gastrin‑producing tumors.

Lansoprazole may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Diarrhea: loose stools that may be self‑limiting. - Nausea: feeling of unease or urge to vomit. - Abdominal pain: discomfort in the stomach area. - Flatulence: excess gas causing bloating. - Constipation: difficulty passing stools.

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis, Stevens‑Johnson syndrome): require immediate medical attention. - Clostridioides difficile infection: can cause severe colitis. - Elevated liver enzymes: indicate possible hepatic involvement. - Hypomagnesemia: low magnesium levels that may cause muscle cramps or arrhythmias. - Increased risk of bone fractures: associated with long‑term use. - Acute interstitial nephritis: inflammation of kidney tissue.

When prescribing or dispensing Lansoprazolo Alter, consider the following precautions.

- Assess renal function: dose adjustment may be needed in severe impairment. - Monitor for infections: reduced acid may increase susceptibility to gastrointestinal infections. - Evaluate need for long‑term therapy: prolonged use is linked to bone and mineral disturbances. - Review concomitant medications that alter gastric pH: may affect absorption of other drugs. - Use with caution in elderly patients: higher risk of adverse events. - Store at room temperature: keep in the original pack, protect from moisture.

Lansoprazole can affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Atazanavir: reduced absorption leading to loss of antiviral efficacy. - Nelfinavir: decreased plasma levels compromising HIV treatment. - Rilpivirine: diminished exposure, risking therapeutic failure. - Methotrexate: increased systemic exposure may cause toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: potential alteration of anticoagulant effect, monitor INR. - Digoxin: possible increase in serum concentration, watch for toxicity. - Phenytoin: reduced clearance, may require dose adjustment. - Clopidogrel: decreased activation, reducing antiplatelet effect. - Ketoconazole: lowered absorption, may need alternative antifungal.